Novartis: New hope for HR+/HER2- Advanced Breast Cancer Patients
Novartis Pharma SAE (Novartis Egypt) has announced final overall survival (OS) results for the Phase III MONALEESA-2 study. The study...
Read moreDetailsNovartis Pharma SAE (Novartis Egypt) has announced final overall survival (OS) results for the Phase III MONALEESA-2 study. The study...
Read moreDetailsGENEVA - The head of the World Health Organisation (WHO) voiced concern on Tuesday that some countries were introducing blanket...
Read moreDetailsThe Prime Speed Medical is in the process of opening the first phase of the general hospital that the company...
Read moreDetailsHONG KONG/SYDNEY - The chief executive of drugmaker Moderna set off fresh alarm bells in financial markets on Tuesday with...
Read moreDetailsTOKYO — Japan confirmed on Tuesday its first case of the new omicron coronavirus variant, a Namibian diplomat who recently...
Read moreDetailsGENEVA — The World Health Organisation is opening a long-planned special session of member states to discuss ways to strengthen...
Read moreDetailsCAIRO - No infections with Omicron have been detected in Egypt so far, the spokesman for the Health Ministry assured...
Read moreDetailsJERUSALEM — Israel on Sunday approved barring entry to foreign nationals and the use of controversial technology for contact tracing...
Read moreDetailsHONG KONG — Australian officials confirmed Sunday that two overseas travelers arriving in Sydney are the first to test positive...
Read moreDetailsTHE HAGUE, Netherlands - With each passing hour, new restrictions were being slapped on travel from countries in southern Africa...
Read moreDetailsCopyrights for © Egyptian Gazette - Administered by Digital Transformation Management.
Copyrights for © Egyptian Gazette - Administered by Digital Transformation Management.




